menu search

Windtree Announces Istaroxime Scientific Abstract Has Been Accepted at the 2023 Technology and Heart Failure Therapeutics Conference

Windtree Announces Istaroxime Scientific Abstract Has Been Accepted at the 2023 Technology and Heart Failure Therapeutics Conference
WARRINGTON, Pa., Feb. 27, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, is targeting cardiogenic shock as a potential indication for its drug candidate, istaroxime. The Company announced that its abstract entitled “Safety and Efficacy of Istaroxime 1.0 […] The post Windtree Announces Istaroxime Scientific Abstract Has Been Accepted at the 20... Read More
Posted: Feb 27 2023, 13:00
Author Name: forextv
Views: 082257

Search within

Pages Search Results: